MiRNAs and diabetes mellitus

Expert Review of Endocrinology and Metabolism

Volumn 7, Issue 3, 2012, Pages 281-300

  Karolina, Dwi Setyowati ^a   Armugam, Arunmozhiarasi ^a   Sepramaniam, Sugunavathi ^a   Jeyaseelan, Kandiah ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

diabetes; gene regulators; insulin signaling; lipid metabolism; miRNAs

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN B; APOLIPOPROTEIN C; APOLIPOPROTEIN E; CHYLOMICRON; FAT DROPLET; FATTY ACID; GLUCOSE; GLYCEROL; MICRORNA; MICRORNA 125B; MICRORNA 221; MICRORNA 222; MICRORNA 320; MICRORNA 503; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; SMALL UNTRANSLATED RNA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; BIOGENESIS; CATARACT; CELL DIFFERENTIATION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; ENDOTHELIAL DYSFUNCTION; GLAUCOMA; GLUCOSE METABOLISM; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LIPID METABOLISM; LIVER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE;

EID: 84862096597     PISSN: 17446651     EISSN: 17448417     Source Type: Journal    
DOI: 10.1586/eem.12.21     Document Type: Review

References (128)

1. Shantikumar S, Caporali A, Emanueli C. Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc. Res. 93 (4), 583-593 (2012).
2. Poy MN, Eliasson L, Krutzfeldt J et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432 (7014), 226-230 (2004). (Pubitemid 39545853)
3. Ferland-McCollough D, Ozanne SE, Siddle K, Willis AE, Bushell M. The involvement of microRNAs in Type 2 diabetes. Biochem. Soc. Trans. 38 (6), 1565-1570 (2010).
4. Herrera BM, Lockstone HE, Taylor JM et al. Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of Type 2 diabetes. Diabetologia 53 (6), 1099-1109 (2010).
5. Roggli E, Britan A, Gattesco S et al. Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells. Diabetes 59 (4), 978-986 (2010).
6. Li S, Chen X, Zhang H et al. Differential expression of microRNAs in mouse liver under aberrant energy metabolic status. J. Lipid Res. 50 (9), 1756-1765 (2009).
7. Lovis P, Roggli E, Laybutt DR et al. Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes 57 (10), 2728-2736 (2008).
8. Karolina DS, Armugam A, Tavintharan S et al. MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in Type 2 diabetes mellitus. PLoS ONE 6 (8), e22839 (2011).
9. Chen X, Ba Y, Ma L et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18 (10), 997-1006 (2008).
10. Zampetaki A, Kiechl S, Drozdov I et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in Type 2 diabetes. Circ. Res. 107 (6), 810-817 (2010).
11. Kong L, Zhu J, Han W et al. Significance of serum microRNAs in pre-diabetes and newly diagnosed Type 2 diabetes: a clinical study. Acta Diabetol. 48 (1), 61-69 (2011).
12. Kantharidis P, Wang B, Carew RM, Lan HY. Diabetes complications: the microRNA perspective. Diabetes 60 (7), 1832-1837 (2011).
13. Pandey AK, Agarwal P, Kaur K, Datta M. MicroRNAs in diabetes: tiny players in big disease. Cell Physiol. Biochem. 23 (4-6), 221-232 (2009).
14. Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in Type 1 diabetes. Nature 464 (7293), 1293-1300 (2010).
15. Daneman D. Type 1 diabetes. Lancet 367 (9513), 847-858 (2006). (Pubitemid 43363372)
16. Jun HS, Yoon JW. A new look at viruses in Type 1 diabetes. Diabetes Metab. Res. Rev.19 (1), 8-31 (2003).
17. Adeghate E, Schattner P, Dunn E. An update on the etiology and epidemiology of diabetes mellitus. Ann. NY Acad. Sci. 1084, 1-29 (2006). (Pubitemid 47091962)
18. McCarthy MI. Genomics, Type 2 diabetes, and obesity. N. Engl. J. Med. 363 (24), 2339-2350 (2010).
19. Gastaldelli A. Role of beta-cell dysfunction, ectopic fat accumulation and insulin resistance in the pathogenesis of Type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 93 (Suppl. 1), S60-S65 (2011).
20. Scheen AJ. Pathophysiology of Type 2 diabetes. Acta Clin. Belg. 58 (6), 335-341 (2003). (Pubitemid 38325707)
21. Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care 29 (9), 2114-2116 (2006). (Pubitemid 44871196)
22. Scalea JR, Cooper M. Surgical strategies for Type II diabetes. Transplant. Rev. doi:10.1016/j.trre.2011.07.002 (2011) (Epub ahead of print).
23. Schernthaner G, Morton JM. Bariatric surgery in patients with morbid obesity and Type 2 diabetes. Diabetes Care 31 (Suppl. 2), S297-S302 (2008).
24. Prevalence of overweight and obesity among adults with diagnosed diabetes-United States, 1988-1994 and 1999-2002. MMWR Morbid. Mortal. Wkly Rep. 53 (45), 1066-1068 (2004).
25. Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of Type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 54 (10), 2506-2514 (2011).
26. Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol. 6 (5), 376-385 (2005). (Pubitemid 40637855)
27. Berezikov E, Cuppen E, Plasterk RH. Approaches to microRNA discovery. Nat. Genet. 38 (Suppl.), S2-S7 (2006).
28. Shivdasani RA. MicroRNAs: regulators of gene expression and cell differentiation. Blood 108 (12), 3646-3653 (2006). (Pubitemid 44864540)
29. Khvorova A, Reynolds A, Jayasena SD. Functional siRNAs and miRNAs exhibit strand bias. Cell 115 (2), 209-216 (2003). (Pubitemid 37329584)
30. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2), 281-297 (2004).
31. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19 (1), 92-105 (2009).
32. Lim LP, Lau NC, Garrett-Engele P et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433 (7027), 769-773 (2005). (Pubitemid 40292988)
33. Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc. Natl Acad. Sci. USA 105 (5), 1608-1613 (2008). (Pubitemid 351346562)
34. Li LC, Okino ST, Zhao H et al. Small dsRNAs induce transcriptional activation in human cells. Proc. Natl Acad. Sci. USA 103 (46), 17337-17342 (2006). (Pubitemid 44788970)
35. Mortensen RD, Serra M, Steitz JA, Vasudevan S. Posttranscriptional activation of gene expression in Xenopus laevis oocytes by microRNA-protein complexes (microRNPs). Proc. Natl Acad. Sci. USA 108 (20), 8281-8286 (2011).
36. Majid S, Dar AA, Saini S et al. MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer. Cancer 116 (24), 5637-5649 (2010).
37. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 20 (5), 515-524 (2006). (Pubitemid 43345317)
38. Eulalio A, Behm-Ansmant I, Izaurralde E. P bodies: at the crossroads of posttranscriptional pathways. Nat. Rev. Mol. Cell Biol. 8 (1), 9-22 (2007).
39. Lynn FC, Skewes-Cox P, Kosaka Y, McManus MT, Harfe BD, German MS. MicroRNA expression is required for pancreatic islet cell genesis in the mouse. Diabetes 56 (12), 2938-2945 (2007). (Pubitemid 350223628)
40. Melkman-Zehavi T, Oren R, Kredo-Russo S et al. miRNAs control insulin content in pancreatic β-cells via downregulation of transcriptional repressors. EMBO J. 30 (5), 835-845 (2011).
41. Gauthier BR, Wollheim CB. MicroRNAs: 'ribo-regulators' of glucose homeostasis. Nat. Med. 12 (1), 36-38 (2006). (Pubitemid 43050057)
42. Tang X, Tang G, Ozcan S. Role of microRNAs in diabetes. Biochim. Biophys. Acta 1779, 697-701 (2008).
43. Poy MN, Hausser J, Trajkovski M et al. miR-375 maintains normal pancreatic alpha-and beta-cell mass. Proc. Natl Acad. Sci. USA 106 (14), 5813-5818 (2009).
44. Plaisance V, Abderrahmani A, Perret-Menoud V, Jacquemin P, Lemaigre F, Regazzi R. MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. J. Biol. Chem. 281 (37), 26932-26942 (2006). (Pubitemid 44401722)
45. Huang B, Qin W, Zhao B et al. MicroRNA expression profiling in diabetic GK rat model. Acta Biochim. Biophys. Sin. 41 (6), 472-477 (2009).
46. Baroukh N, Ravier MA, Loder MK et al. MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic beta-cell lines. J. Biol. Chem. 282 (27), 19575-19588 (2007). (Pubitemid 47100119)
47. Hennessy E, Clynes M, Jeppesen PB, O'Driscoll L. Identification of microRNAs with a role in glucose stimulated insulin secretion by expression profiling of MIN6 cells. Biochem. Biophys. Res. Commun. 396 (2), 457-462 (2010).
48. Tang X, Muniappan L, Tang G, Ozcan S. Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription. RNA 15 (2), 287-293 (2009).
49. Sekine S, Ogawa R, Mcmanus MT, Kanai Y, Hebrok M. Dicer is required for proper liver zonation. J. Pathol. 219 (3), 365-372 (2009).
50. Herrera BM, Lockstone HE, Taylor JM et al. MicroRNA-125a is over-expressed in insulin target tissues in a spontaneous rat model of Type 2 diabetes. BMC Med. Genomics 2, 54 (2009).
51. Alexander R, Lodish H, Sun L. MicroRNAs in adipogenesis and as therapeutic targets for obesity. Expert Opin. Ther. Targets 15 (5), 623-636 (2011).
52. Xie H, Lim B, Lodish HF. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 58 (5), 1050-1057 (2009).
53. Jordan SD, Krüger M, Willmes DM et al. Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat. Cell Biol. 13 (4), 434-446 (2011).
54. Wilfred BR, Wang WX, Nelson PT. Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol. Genet. Metab. 91 (3), 209-217 (2007). (Pubitemid 46819124)
55. Zaragosi LE, Wdziekonski B, Brigand KL et al. Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis. Genome Biol. 12 (7), R64 (2011).
56. Karbiener M, Fischer C, Nowitsch S et al. microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma. Biochem. Biophys. Res. Commun. 390 (2), 247-251 (2009).
57. Martinelli R, Nardelli C, Pilone V et al. miR-519d overexpression is associated with human obesity. Obesity 18 (11), 2170-2176 (2010).
58. He A, Zhu L, Gupta N, Chang Y, Fang F. Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol. Endocrinol. 21 (11), 2785-2794 (2007). (Pubitemid 350035159)
59. Ling HY, Ou HS, Feng SD et al. Changes in microRNA profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes. Clin. Exp. Pharmacol. Physiol. doi:10.1111/j.1440-1681.2009.05207.x (2009) (Epub ahead of print).
60. Granjon A, Gustin MP, Rieusset J et al. The microRNA signature in response to insulin reveals its implication in the transcriptional action of insulin in human skeletal muscle and the role of a sterol regulatory element-binding protein-1c/ myocyte enhancer factor 2C pathway. Diabetes 58 (11), 2555-2564 (2009).
61. Gallagher IJ, Scheele C, Keller P et al. Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in Type 2 diabetes. Genome Med. 2 (2), 9 (2010).
62. Nielsen S, Scheele C, Yfanti C et al. Muscle specific microRNAs are regulated by endurance exercise in human skeletal muscle. J. Physiol. 588 (Pt 20), 4029-4037 (2010).
63. Horie T, Ono K, Nishi H et al. MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes. Biochem. Biophys. Res. Commun. 389 (2), 315-320 (2009).
64. Luo X, Xiao J, Lin H et al. Transcriptional activation by stimulating protein 1 and post-transcriptional repression by muscle-specific microRNAs of IKsencoding genes and potential implications in regional heterogeneity of their expressions. J. Cell. Physiol. 212 (2), 358-367 (2007). (Pubitemid 47025625)
65. Zhang Y, Xiao J, Lin H et al. Ionic mechanisms underlying abnormal QT prolongation and the associated arrhythmias in diabetic rabbits: a role of rapid delayed rectifier K+ current. Cell Physiol. Biochem. 19 (5-6), 225-238 (2007). (Pubitemid 46701498)
66. Yu XY, Song YH, Geng YJ et al. Glucose induces apoptosis of cardiomyocytes via microRNA-1 and IGF-1. Biochem. Biophys. Res. Commun. 376 (3), 548-552 (2008).
67. Elia L, Contu R, Quintavalle M et al. Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation 120 (23), 2377-2385 (2009).
68. Keren A, Tamir Y, Bengal E. The p38 MAPK signaling pathway: a major regulator of skeletal muscle development. Mol. Cell. Endocrinol. 252 (1-2), 224-230 (2006).
69. Guo C, Sah JF, Beard L, Willson JK, Markowitz SD, Guda K. The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer 47 (11), 939-946 (2008).
70. Li JY, Yong TY, Michael MZ, Gleadle JM. Review: the role of microRNAs in kidney disease. Nephrology 15 (6), 599-608 (2010).
71. Kato M, Zhang J, Wang M et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-betainduced collagen expression via inhibition of E-box repressors. Proc. Natl Acad. Sci. USA 104 (9), 3432-3437 (2007). (Pubitemid 46364176)
72. Kato M, Wang L, Putta S et al. Posttranscriptional up-regulation of Tsc-22 by Ybx1, a target of miR-216a, mediates TGF-{beta}-induced collagen expression in kidney cells. J. Biol. Chem. 285 (44),34004-34015 (2010).
73. Krupa A, Jenkins R, Luo DD, Lewis A, Phillips A, Fraser D. Loss of microRNA-192 promotes fibrogenesis in diabetic nephropathy. J. Am. Soc. Nephrol. 21 (3), 438-447 (2010).
74. Wang B, Herman-Edelstein M, Koh P et al. E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta. Diabetes 59 (7), 1794-1802 (2010).
75. Gregory PA, Bert AG, Paterson EL et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10 (5), 593-601 (2008). (Pubitemid 351627379)
76. Wang B, Koh P, Winbanks C et al. miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression. Diabetes 60 (1), 280-287 (2011).
77. Liu Y, Taylor NE, Lu L et al. Renal medullary microRNAs in Dahl saltsensitive rats: miR-29b regulates several collagens and related genes. Hypertension 55 (4), 974-982 (2010).
78. Zhang Z, Peng H, Chen J et al. MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice. FEBS Lett. 583 (12), 2009-2014 (2009).
79. Wang Q, Wang Y, Minto AW et al. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J. 22 (12), 4126-4135 (2008).
80. Long J, Wang Y, Wang W, Chang BH, Danesh FR. Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J. Biol. Chem. 285 (30), 23457-23465 (2010).
81. McArthur K, Feng B, Wu Y, Chen S, Chakrabarti S. MicroRNA-200b regulates vascular endothelial growth factormediated alterations in diabetic retinopathy. Diabetes 60 (4), 1314-1323 (2011).
82. Kovacs B, Lumayag S, Cowan C, Xu S. MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats. Invest. Ophthalmol. Vis. Sci. 52 (7), 4402-4409 (2011).
83. Carè A, Catalucci D, Felicetti F et al. MicroRNA-133 controls cardiac hypertrophy. Nat. Med. 13 (5), 613-618 (2007). (Pubitemid 46828487)
84. Shan YX, Liu TJ, Su HF, Samsamshariat A, Mestril R, Wang PH. Hsp10 and Hsp60 modulate Bcl-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac muscle cells. J. Mol. Cell. Cardiol. 35 (9), 1135-1143 (2003). (Pubitemid 37083257)
85. Thum T, Gross C, Fiedler J et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456 (7224), 980-984 (2008).
86. van Rooij E, Sutherland LB, Thatcher JE et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl Acad. Sci. USA 105 (35), 13027-13032 (2008).
87. Wang XH, Qian RZ, Zhang W, Chen SF, Jin HM, Hu RM. MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in Type 2 diabetic rats. Clin. Exp. Pharmacol. Physiol. 36 (2), 181-188 (2009).
88. Ortega FJ, Moreno-Navarrete JM, Pardo G et al. MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation. PLoS ONE 5 (2), e9022 (2010).
89. Takanabe R, Ono K, Abe Y et al. Upregulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet. Biochem. Biophys. Res. Commun. 376 (4), 728-732 (2008).
90. Klöting N, Berthold S, Kovacs P et al. MicroRNA expression in human omental and subcutaneous adipose tissue. PLoS ONE 4 (3), e4699 (2009).
91. Heneghan HM, Miller N, McAnena OJ, O'Brien T, Kerin MJ. Differential miRNA expression in omental adipose tissue and in he circulation of obese patients identifies novel metabolic biomarkers. J. Clin. Endocrinol. Metab. 96 (5), E846-E850 (2011).
92. Esau C, Davis S, Murray SF et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 3 (2), 87-98 (2006).
93. Elmén J, Lindow M, Schütz S et al. LNA-mediated microRNA silencing in non-human primates. Nature 452 (7189), 896-899 (2008). (Pubitemid 351550859)
94. Iliopoulos D, Drosatos K, Hiyama Y, Goldberg IJ, Zannis VI. MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J. Lipid Res. 51 (6), 1513-1523 (2010).
95. Gerin I, Bommer GT, McCoin CS, Sousa KM, Krishnan V, MacDougald OA. Roles for miRNA-378/378* in adipocyte gene expression and lipogenesis. Am. J. Physiol. Endocrinol. Metab. 299 (2), E198-E206 (2010).
96. Rayner KJ, Suárez Y, Dávalos A et al. miR-33 contributes to the regulation of cholesterol homeostasis. Science 328 (5985), 1570-1573 (2010).
97. Najafi-Shoushtari SH, Kristo F, Li Y et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 328 (5985), 1566-1569 (2010).
98. Marquart TJ, Allen RM, Ory DS, Baldán A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc. Natl Acad. Sci. USA 107 (27), 12228-12232 (2010).
99. Horie T, Ono K, Horiguchi M et al. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc. Natl Acad. Sci. USA 107 (40), 17321-17326 (2010).
100. Wang MD, Franklin V, Sundaram M et al. Differential regulation of ATP binding cassette protein A1 expression and ApoA-I lipidation by Niemann-Pick type C1 in murine hepatocytes and macrophages. J. Biol. Chem. 282 (31), 22525-22533 (2007). (Pubitemid 47267343)
101. Rayner KJ, Esau CC, Hussain FN et al. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 478 (7369), 404-407 (2011).
102. Laterza OF, Lim L, Garrett-Engele PW et al. Plasma microRNAs as sensitive and specific biomarkers of tissue injury. Clin. Chem. 55 (11), 1977-1983 (2009).
103. Jeyaseelan K, Lim KY, Armugam A. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke 39 (3), 959-966 (2008). (Pubitemid 351619577)
104. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 285, 17442-17452 (2010).
105. Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J. Proteomics 73 (10), 1907-1920 (2010).
106. Hezova R, Slaby O, Faltejskova P et al. microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of Type 1 diabetic patients. Cell. Immunol. 260 (2), 70-74 (2010).
107. Sebastiani G, Grieco FA, Spagnuolo I, Galleri L, Cataldo D, Dotta F. Increased expression of microRNA miR-326 in Type 1 diabetic patients with ongoing islet autoimmunity. Diabetes Metab. Res. Rev. 27 (8), 862-866 (2011).
108. Etheridge A, Lee I, Hood L, Galas D, Wang K. Extracellular microRNA: a new source of biomarkers. Mutat. Res. 717 (1-2), 85-90 (2011).
109. Goldstein SL. Urinary kidney injury biomarkers and urine creatinine normalization: a false premise or not? Kidney Int. 78 (5), 433-435 (2010).
110. Wagner BD, Accurso FJ, Laguna TA. The applicability of urinary creatinine as a method of specimen normalization in the cystic fibrosis population. J. Cyst. Fibros. 9 (3), 212-216 (2010).
111. Bader AG, Brown D, Winkler M. The promise of microRNA replacement therapy. Cancer Res. 70 (18), 7027-7030 (2010).
112. Zhao E, Keller MP, Rabaglia ME et al. Obesity and genetics regulate microRNAs in islets, liver, and adipose of diabetic mice. Mamm. Genome 20 (8), 476-485 (2009).
113. Nakanishi N, Nakagawa Y, Tokushige N et al. The up-regulation of microRNA-335 is associated with lipid metabolism in liver and white adipose tissue of genetically obese mice. Biochem. Biophys. Res. Commun. 385 (4), 492-496 (2009).
114. El Ouaamari A, Baroukh N, Martens GA, Lebrun P, Pipeleers D, van Obberghen E. iR-375 targets 3′-phosphoinositidedependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes 57 (10), 2708-2717 (2008).
115. Lovis P, Gattesco S, Regazzi R. Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs. Biol. Chem. 389 (3), 305-312 (2008). (Pubitemid 351329024)
116. Sun T, Fu M, Bookout AL, Kliewer SA, Mangelsdorf DJ. MicroRNA let-7 regulates 3T3-L1 adipogenesis. Mol. Endocrinol. 23 (6), 925-931 (2009).
117. Qin L, Chen Y, Niu Y et al. A deep investigation into the adipogenesis mechanism: profile of microRNAs regulating adipogenesis by modulating the canonical Wnt/beta-catenin signaling pathway. BMC Genomics 11, 320 (2010).
118. Kajimoto K, Naraba H, Iwai N. MicroRNA and 3T3-L1 pre-adipocyte differentiation. RNA 12 (9), 1626-1632 (2006). (Pubitemid 44316027)
119. Andersen DC, Jensen CH, Schneider M et al. MicroRNA-15a fine-tunes the level of Delta-like 1 homolog (DLK1) in proliferating 3T3-L1 preadipocytes. Exp. Cell Res. 316 (10), 1681-1691 (2010).
120. Wang Q, Li YC, Wang J et al. miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130. Proc. Natl Acad. Sci. USA 105 (8), 2889-2894 (2008). (Pubitemid 351723639)
121. Strum JC, Johnson JH, Ward J et al. MicroRNA 132 regulates nutritional stress-induced chemokine production through repression of SirT1. Mol. Endocrinol. 23 (11), 1876-1884 (2009).
122. Walden TB, Timmons JA, Keller P, Nedergaard J, Cannon B. Distinct expression of muscle-specific microRNAs (myomirs) in brown adipocytes. J. Cell. Physiol. 218 (2), 444-449 (2009).
123. Yang Z, Bian C, Zhou H et al. MicroRNA hsa-miR-138 inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells through adenovirus EID-1. Stem Cells Dev. 20 (2), 259-267 (2011).
124. Kennell JA, Gerin I, MacDougald OA, Cadigan KM. The microRNA miR-8 is a conserved negative regulator of Wnt signaling. Proc. Natl Acad. Sci. USA 105 (40), 15417-15422 (2008).
125. Kim YJ, Hwang SJ, Bae YC, Jung JS. miR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells 27 (12), 3093-3102 (2009).
126. Sun F, Wang J, Pan Q et al. Characterization of function and regulation of miR-24-1 and miR-31. Biochem. Biophys. Res. Commun. 380 (3), 660-665 (2009).
127. Tang YF, Zhang Y, Li XY, Li C, Tian W, Liu L. Expression of miR-31, miR-125b-5p, and miR-326 in the adipogenic differentiation process of adipose-derived stem cells. OMICS 13 (4), 331-336 (2009).
128. Kinoshita M, Ono K, Horie T et al. Regulation of adipocyte differentiation by activation of serotonin (5-HT) receptors 5-HT2AR and 5-HT2CR and involvement of microRNA-448-mediated repression of KLF5. Mol. Endocrinol. 24 (10), 1978-1987 (2010).